Viewing Study NCT02598427

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:06 AM

Ignite Modification Date: 2025-12-26 @ 4:10 AM

Study NCT ID: NCT02598427

Status: TERMINATED

Last Update Posted: 2018-02-28

First Post: 2015-11-04

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

Sponsor: Kimberly Blackwell

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module